IFP Advisors’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
Other funds holding LUNG
SCM
ECM
AC
SCM
B
IFP Advisors's LUNG Position: Q2 2026 in Review
IFP Advisors reduced its Pulmonx (LUNG) stake by 52% in Q2 2026, selling an estimated $113 and leaving 76 shares worth $99. The position accounts for ﹤0.01% of the portfolio, ranked #4958.
IFP Advisors first reported a position in LUNG in Q4 2024 and has held it in 6 quarters since. The position peaked at $204 in Q1 2026. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.
- IFP Advisors held 76 shares of Pulmonx worth $99 as of Q2 2026.
- IFP Advisors sold 82 Pulmonx shares in Q2 2026, an estimated $113.
- Pulmonx made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4958 holding.
- IFP Advisors first reported a position in Pulmonx in Q4 2024 and has held it in 6 quarters since.
- IFP Advisors's Pulmonx position peaked at $204 in Q1 2026.
- 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.